Icon

INPEFA - (200MG, 400MG)

SOTAGLIFLOZIN None
200MG, 400MG
Less Than $1000 mn
None None
None None
None None
INPEFA is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with: • heart failure or • type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.
Yes
INPEFA Patent 1 Patent 2 Patent 3
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.